Steven Mitchell Kornblau

37PUBLICATIONS
240CO-AUTHORS
Cellular immunologyGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Apr 17, 2026
Intracellular IL-23R is necessary for mitotic spindle formation and viability in AML.

|Feb 17, 2026
A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia.

Samarpana Chakraborty, Claudia Morganti, Kimberly Zaldana

|Jun 13, 2025
Outcomes of Frontline Triplet Regimens With a Hypomethylating Agent, Venetoclax, and Isocitrate Dehydrogenase Inhibitor for Intensive Chemotherapy-Ineligible Patients With Isocitrate Dehydrogenase-Mutated AML.

Courtney D DiNardo, Jennifer Marvin-Peek, Sanam Loghavi

|Feb 25, 2025
Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia.

Courtney D DiNardo, Wei-Ying Jen, Koichi Takahashi

|Jan 08, 2025
The Proteomics of T-Cell and Early T-Cell Precursor (ETP) Acute Lymphocytic Leukemia: Prognostic Patterns in Adult and Pediatric-ETP ALL.

Fieke W Hoff, Lourdes Sriraja, Yihua Qiu

|Sep 19, 2024
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses.

Courtney D DiNardo, Divij Verma, Natalia Baran

Pageof 7

Frequent Collaborators

10 joint publications

Guillermo Garcia-Manero

10 joint publications

Gautam Borthakur

10 joint publications

Courtney DiNardo

10 joint publications

Marina Y Konopleva